Canadian CANNAINVESTOR Magazine August / September 2017 - Page 12

CannaInvestor Magazine assumes no responsibility for any claims or representations contained in the magazine or any advertisement. CannaInvestor Magazine considers its sources reliable and verifies as much data as possible, although reporting inaccuracies can occur; consequently, readers using this information do so at their own risk. All materials contained are for educational purposes only. Articles are general information and not a recommendation to act. The author or CannaInvestor Magazine or associated individuals and companies will not be held responsible or be liable for action taken by any reader of our article. Past performance is not a reliable indicator of future performance. Cannabis Stocks involve a higher level of risk and may not be suitable for all investors, losses can exceed deposits. Please seek independent investment advice before entering into any financial transaction.

Editor In Chief

Louis Kyron, CPA, CGA

Contributing Writers

Louis Kyron, CPA, CGA

Spiro Sertsis, CPA, CMA

Ryan Chua, JD/MBA

Dylan Rogers

Jason A. DeJean, CFP, PFP, EPC, CPCA

Dr. Michael Verbora, MBA, MD, CCFP

The Marijuana Index





Dear Subscribers.

Welcome to our fourth issue. The flurry of new capital investment and expansion as the industry ramps to address the looming forecasted supply shortage appears to be met by a resurgence of investor interest, confidence, and participation. It also appears that Ontario has joined New Brunswick in investing as evidenced by the involvement of the Ontario Investment Office in attracting Tilray Canada Ltd to choose Enniskillen for its planned expansion facility. Once completed, privately owned Tilray’s capacity is expected to be 51 metric tonnes.

We are constantly receiving notifications alerting to us that our strategies (such as companies tracked by revenues), topics, case study companies, etc are subsequently being echoed elsewhere by others – even mottos such as “connecting the dots so you don’t have to”. We are here first and foremost as a resource for investors and for the industry itself and that includes becoming a source material for others. Unlike our team of industry leading professional writers, certain others do not provide credit or acknowledgment for their content. How ahead of the pack are we?

I tweeted on August 13th the corporate presentation of Scientus Pharma including the Aphria wholesale arrangement. This company is referenced in this month’s case study #2 as well as in the article written by Spiro Sertsis. On August 15th, Aprhia announced a strategic investment (CLICK HERE).